News
Patients regularly taking Eli Lilly & Co.’s obesity shot Zepbound tend to keep the weight off for at least three years, with ...
We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is ...
Eli Lilly's (LLY) cease-and-desist letter is dismissed by weight loss drug compounder, OrderlyMeds. Read more here.
Eli Lilly (LLY) stock in focus as the company projects earnings headwinds from IPR&D charges estimated at $1.57B for Q1 2025.
GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...
Shares of drug companies including AbbVie, Eli Lilly, Pfizer and Merck were recently up 1% to 2% immediately following Trump's announcement, reversing 3% to 5% drops earlier in the day. The Dow Jones ...
Major” tariffs on pharmaceutical imports are coming soon, President Donald Trump says, pledging that they’d help bring drug ...
Trump doubled down on plans to soon impose “major” pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.
The pharmaceutical and healthcare sectors were previously viewed as a relative safe haven from the tariff-induced market turmoil. The Health Care Select Sector SPDR exchange-traded fund XLV fell 7.8% ...
Shares in many large drugmakers initially fell Wednesday on the president's threat, only to rebound later when he announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results